Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TRAJ2 (T cell receptor alpha joining 2) is a genomic segment located in the T cell receptor alpha locus on chromosome 14. It is a J (joining) region that participates in the somatic recombination generating functional T cell receptor alpha chains. The full T cell receptor (TCR) is a heterodimeric protein complex present on the surface of T lymphocytes, recognizing peptide antigens presented by MHC molecules and initiating adaptive immune responses. TRAJ2 itself is non-functional in terms of protein coding, and serves merely as one of many possible joining segments combined with variable (V) regions to create diverse antigen-binding repertoires. Some joining segments in the TCR alpha locus, including TRAJ2, may be classified as pseudogenes if incapable of encoding protein. Key clarification: TRAJ2 is not a receptor or standalone therapeutic target, but a join segment of the TCR alpha locus used during gene rearrangement in thymocyte development. The actual immune receptor is the multi-chain T cell receptor complex (TCR), which mediates T cell activation; TRAJ2 is only one small part of the genomic architecture underlying TCR diversity.
Not applicable, as TRAJ2 is not targeted by drugs. Mechanistic drug actions apply to the TCR complex, not individual joining segments
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T cell receptor alpha joining 2 (non-functional) (TRAJ2).